TrialInternational journal of cancer2023

Late toxicity comparison of alkylating-based maintenance regimen with cyclophosphamide (VAC) vs ifosfamide (VAI) in Ewing sarcoma survivors treated in the randomized clinical trial Euro-EWING99-R1 in France.

Victoria Corvest et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.